Sleep, Dietary Melatonin Supplementation, and COVID-19
- 作者: Gasmi A.1, Semenova Y.2, Noor S.3, Benahmed A.4, Bjørklund G.5
-
隶属关系:
- , Société Francophone de Nutrithérapie et de Nutrigénétique Appliquée
- School of Medicine, Nazarbayev University
- Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University
- Department of Research, Académie Internationale de Médecine Dentaire Intégrative
- Department of Research,, Council for Nutritional and Environmental Medicine (CONEM)
- 期: 卷 31, 编号 11 (2024)
- 页面: 1298-1314
- 栏目: Anti-Infectives and Infectious Diseases
- URL: https://rjmseer.com/0929-8673/article/view/644180
- DOI: https://doi.org/10.2174/0929867330666230224093849
- ID: 644180
如何引用文章
全文:
详细
Background:During the COVID-19 pandemic, people suffered from major mental health problems. These include stress, anxiety, and confusion about the existing situation of home confinement. Melatonin is a popular anti-inflammatory and antioxidant molecule sold as an over-the-counter dietary supplement.
Objective:This review discusses the indications for using melatonin in the context of the COVID-19 pandemic, including treatment.
Methods:A comprehensive search of publications was conducted in electronic databases focusing on the administration of melatonin in COVID-19.
Results:Stress has a huge negative impact on sleep routines and the quality of life of individuals. Sleep is considered an important modulator of the immune response. Thus, a lack of sleep can weaken immunity, increasing organism susceptibility to infection. For instance, shorter sleep durations are associated with a rise in suffering from the common cold. The administration of melatonin protects against viral and other pathogens and speeds clinical recovery.
Conclusion:In patients admitted to intensive care units, melatonin decreases the risks of severe complications, such as thrombosis and sepsis, and mortality rates. In addition, it is efficacious in lowering vessel permeability, depression, and sedation, and improving the quality of sleep, which could also help COVID-19 patients achieve better clinical outcomes.
作者简介
Amin Gasmi
, Société Francophone de Nutrithérapie et de Nutrigénétique Appliquée
Email: info@benthamscience.net
Yuliya Semenova
School of Medicine, Nazarbayev University
Email: info@benthamscience.net
Sadaf Noor
Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University
Email: info@benthamscience.net
Asma Benahmed
Department of Research, Académie Internationale de Médecine Dentaire Intégrative
Email: info@benthamscience.net
Geir Bjørklund
Department of Research,, Council for Nutritional and Environmental Medicine (CONEM)
编辑信件的主要联系方式.
Email: info@benthamscience.net
参考
- Cui, J.; Li, F.; Shi, Z.L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol., 2019, 17(3), 181-192. doi: 10.1038/s41579-018-0118-9 PMID: 30531947
- Martín, G.V.M.; Inserra, F.; Tajer, C.D.; Mariani, J.; Ferder, L.; Reiter, R.J.; Manucha, W. Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment. Life Sci., 2020, 254, 117808-117808. doi: 10.1016/j.lfs.2020.117808 PMID: 32422305
- Semenova, Y.; Trenina, V.; Pivina, L.; Glushkova, N.; Zhunussov, Y.; Ospanov, E.; Bjørklund, G. The lessons of COVID-19, SARS, and MERS: Implications for preventive strategies. Int. J. Healthc. Manag., 2022, 15(4), 314-324. doi: 10.1080/20479700.2022.2051126
- Semenova, Y.; Kalmatayeva, Z.; Oshibayeva, A.; Mamyrbekova, S.; Kudirbekova, A.; Nurbakyt, A.; Baizhaxynova, A.; Colet, P.; Glushkova, N.; Ivankov, A.; Sarria-Santamera, A. Seropositivity of SARS-CoV-2 in the population of Kazakhstan: A nationwide laboratory-based surveillance. Int. J. Environ. Res. Public Health, 2022, 19(4), 2263. doi: 10.3390/ijerph19042263 PMID: 35206453
- Greenberg, N.; Docherty, M.; Gnanapragasam, S.; Wessely, S. Managing mental health challenges faced by healthcare workers during COVID-19 pandemic. BMJ, 2020, 368, m1211. doi: 10.1136/bmj.m1211 PMID: 32217624
- Wang, G.; Zhang, Y.; Zhao, J.; Zhang, J.; Jiang, F. Mitigate the effects of home confinement on children during the COVID-19 outbreak. Lancet, 2020, 395(10228), 945-947. doi: 10.1016/S0140-6736(20)30547-X PMID: 32145186
- Cohen, S.; Doyle, W.J.; Alper, C.M.; Janicki-Deverts, D.; Turner, R.B. Sleep habits and susceptibility to the common cold. Arch. Intern. Med., 2009, 169(1), 62-67. doi: 10.1001/archinternmed.2008.505 PMID: 19139325
- Glaser, R.; Kiecolt-Glaser, J.K. Stress-induced immune dysfunction: Implications for health. Nat. Rev. Immunol., 2005, 5(3), 243-251. doi: 10.1038/nri1571 PMID: 15738954
- Besedovsky, L.; Lange, T.; Born, J. Sleep and immune function. Pflugers Arch., 2012, 463(1), 121-137. doi: 10.1007/s00424-011-1044-0 PMID: 22071480
- Wright, J.H.; Caudill, R. Remote treatment delivery in response to the COVID-19 pandemic. Psychother. Psychosom., 2020, 89(3), 130-132. doi: 10.1159/000507376 PMID: 32213775
- Reiter, R.J.; Ma, Q.; Sharma, R. Melatonin in mitochondria: Mitigating clear and present dangers. Physiology, 2020, 35(2), 86-95. doi: 10.1152/physiol.00034.2019 PMID: 32024428
- Benington, J.H.; Craig Heller, H. Restoration of brain energy metabolism as the function of sleep. Prog. Neurobiol., 1995, 45(4), 347-360. doi: 10.1016/0301-0082(94)00057-O PMID: 7624482
- Mackiewicz, M.; Shockley, K.R.; Romer, M.A.; Galante, R.J.; Zimmerman, J.E.; Naidoo, N.; Baldwin, D.A.; Jensen, S.T.; Churchill, G.A.; Pack, A.I. Macromolecule biosynthesis: A key function of sleep. Physiol. Genomics, 2007, 31(3), 441-457. doi: 10.1152/physiolgenomics.00275.2006 PMID: 17698924
- Dimitrov, S.; Lange, T.; Nohroudi, K.; Born, J. Number and function of circulating human antigen presenting cells regulated by sleep. Sleep, 2007, 30(4), 401-411. doi: 10.1093/sleep/30.4.401 PMID: 17520784
- Yehuda, S.; Sredni, B.; Carasso, R.L.; Kenigsbuch-Sredni, D. REM sleep deprivation in rats results in inflammation and interleukin-17 elevation. J Interferon Cytokine Res, 2009, 29(7), 393-398. doi: 10.1089/jir.2008.0080 PMID: 19450150
- Zager, A.; Andersen, M.L.; Ruiz, F.S.; Antunes, I.B.; Tufik, S. Effects of acute and chronic sleep loss on immune modulation of rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2007, 293(1), R504-R509. doi: 10.1152/ajpregu.00105.2007 PMID: 17409265
- Ibarra-Coronado, E.G.; Pantaleón-Martínez, A.M.; Velazquéz-Moctezuma, J.; Prospéro-García, O.; Méndez-Díaz, M.; Pérez-Tapia, M.; Pavón, L.; Morales-Montor, J. The bidirectional relationship between sleep and immunity against infections. J. Immunol. Res., 2015, 2015, 1-14. doi: 10.1155/2015/678164 PMID: 26417606
- Hurtado-Alvarado, G.; Domínguez-Salazar, E.; Pavon, L.; Velázquez-Moctezuma, J.; Gómez-González, B. Blood-brain barrier disruption induced by chronic sleep loss: low-grade inflammation may be the link. J. Immunol. Res., 2016, 2016, 1-15. doi: 10.1155/2016/4576012 PMID: 27738642
- Fang, J.; Sanborn, C.K.; Renegar, K.B.; Majde, J.A.; Krueger, J.M. Influenza viral infections enhance sleep in mice. Exp. Biol. Med., 1995, 210(3), 242-252. doi: 10.3181/00379727-210-43945 PMID: 8539262
- Fang, I.; Tooley, D.; Gatewood, C.; Renegar, K.B.; Majde, J.A.; Krueger, J.M. Differential effects of total and upper airway influenza viral infection on sleep in mice. Sleep, 1996, 19(4), 337-342. PMID: 8776792
- Horváth, A.; Papp, A.; Szűcs, A. Progress in elucidating the pathophysiological basis of nonrapid eye movement parasomnias: not yet informing therapeutic strategies. Nat. Sci. Sleep, 2016, 8, 73-79. PMID: 27022307
- Cooke, G.S.; Hill, A.V.S. Genetics of susceptibitlity to human infectious disease. Nat. Rev. Genet., 2001, 2(12), 967-977. doi: 10.1038/35103577 PMID: 11733749
- Hill, A.V.S. The genomics and genetics of human infectious disease susceptibility. Annu. Rev. Genomics Hum. Genet., 2001, 2(1), 373-400. doi: 10.1146/annurev.genom.2.1.373 PMID: 11701655
- Trammell, R.A.; Liberati, T.A.; Toth, L.A. Host genetic background and the innate inflammatory response of lung to influenza virus. Microbes Infect., 2012, 14(1), 50-58. doi: 10.1016/j.micinf.2011.08.008 PMID: 21920449
- Tuite, A.; Gros, P. The impact of genomics on the analysis of host resistance to infectious disease. Microbes Infect., 2006, 8(6), 1647-1653. doi: 10.1016/j.micinf.2005.11.016 PMID: 16697229
- Toth, L.; Rehg, J.E.; Webster, R.G. Strain differences in sleep and other pathophysiological sequelae of influenza virus infection in naive and immunized mice. J. Neuroimmunol., 1995, 58(1), 89-99. doi: 10.1016/0165-5728(94)00193-R PMID: 7730450
- Dahan, V.; Kimoff, R.J.; Petrof, B.J.; Benedetti, A.; Diorio, D.; Trojan, D.A. Sleep-disordered breathing in fatigued postpoliomyelitis clinic patients. Arch. Phys. Med. Rehabil., 2006, 87(10), 1352-1356. doi: 10.1016/j.apmr.2006.07.256 PMID: 17023245
- Silva, T.M.; Moreira, G.A.; Quadros, A.A.J.; Pradella-Hallinan, M.; Tufik, S.; Oliveira, A.S.B. Analysis of sleep characteristics in post-polio syndrome patients. Arq. Neuropsiquiatr., 2010, 68(4), 535-540. doi: 10.1590/S0004-282X2010000400011 PMID: 20730305
- Steljes, D.G.; Kryger, M.H.; Kirk, B.W.; Millar, T.W. Sleep in postpolio syndrome. Chest, 1990, 98(1), 133-140. doi: 10.1378/chest.98.1.133 PMID: 2361379
- Darko, D.F.; McCutchan, J.A.; Kripke, D.F.; Gillin, J.C.; Golshan, S. Fatigue, sleep disturbance, disability, and indices of progression of HIV infection. Am. J. Psychiatry, 1992, 149(4), 514-520. doi: 10.1176/ajp.149.4.514 PMID: 1554037
- Kanmogne, G.D.; Fonsah, J.Y.; Umlauf, A.; Moul, J.; Doh, R.F.; Kengne, A.M.; Tang, B.; Tagny, C.T.; Nchindap, E.; Kenmogne, L.; Franklin, D.; Njamnshi, D.M.; Mbanya, D.; Njamnshi, A.K.; Heaton, R.K. Attention/working memory, learning and memory in adult cameroonians: Normative data, effects of HIV infection and viral genotype. J. Int. Neuropsychol. Soc., 2020, 26(6), 607-623. doi: 10.1017/S1355617720000120 PMID: 32066518
- Chung, W.S.; Lin, H.H.; Cheng, N.C. The incidence and risk of herpes zoster in patients with sleep disorders. Medicine, 2016, 95(11), e2195. doi: 10.1097/MD.0000000000002195 PMID: 26986095
- Gohier, B.; Goeb, J.L.; Rannou-Dubas, K.; Fouchard, I.; Calès, P.; Garré, J.B. Hepatitis C, alpha interferon, anxiety and depression disorders: A prospective study of 71 patients. World J. Biol. Psychiatry, 2003, 4(3), 115-118. doi: 10.1080/15622970310029904 PMID: 12872204
- Thein, H.H.; Maruff, P.; Krahn, M.; Kaldor, J.M.; Koorey, D.J.; Brew, B.J.; Dore, G.J. Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)- monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment. HIV Med., 2007, 8(3), 192-202. doi: 10.1111/j.1468-1293.2007.00452.x PMID: 17461864
- Sockalingam, S.; Abbey, S.E.; Alosaimi, F.; Novak, M. A review of sleep disturbance in hepatitis C. J. Clin. Gastroenterol., 2010, 44(1), 38-45. doi: 10.1097/MCG.0b013e3181b314ea PMID: 19730115
- Huang, Y.; Zhao, N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: A web-based cross-sectional survey. Psychiatry Res., 2020, 288, 112954-112954. doi: 10.1016/j.psychres.2020.112954 PMID: 32325383
- Torales, J.; OHiggins, M.; Castaldelli-Maia, J.M.; Ventriglio, A. The outbreak of COVID-19 coronavirus and its impact on global mental health. Int. J. Soc. Psychiatry, 2020, 66(4), 317-320. doi: 10.1177/0020764020915212 PMID: 32233719
- Firth, J.; Torous, J. Multidisciplinary research priorities for the COVID-19 pandemic. Lancet Psychiatry, 2020, 7(7), e39. doi: 10.1016/S2215-0366(20)30251-0 PMID: 32563314
- Calvo-Sanz, J.; Tapia-Ayuga, C.E. Blue light emission spectra of popular mobile devices: The extent of user protection against melatonin suppression by built-in screen technology and light filtering software systems. Chronobiol. Int., 2020, 37(7), 1016-1022. doi: 10.1080/07420528.2020.1781149 PMID: 32649241
- Horenstein, A.; Morrison, A.S.; Goldin, P.; ten Brink, M.; Gross, J.J.; Heimberg, R.G. Sleep quality and treatment of social anxiety disorder. Anxiety Stress Coping, 2019, 32(4), 387-398. doi: 10.1080/10615806.2019.1617854 PMID: 31082285
- Hempler, N.F.; Joensen, L.E.; Willaing, I. Relationship between social network, social support and health behaviour in people with type 1 and type 2 diabetes: cross-sectional studies. BMC Public Health, 2016, 16(1), 198. doi: 10.1186/s12889-016-2819-1 PMID: 26926867
- Utz, S.; Breuer, J. The relationship between use of social network sites, online social support, and well-being. J. Media Psychol., 2017, 29(3), 115-125. doi: 10.1027/1864-1105/a000222 PMID: 29147141
- Alvaro, P.K.; Roberts, R.M.; Harris, J.K. A systematic review assessing bidirectionality between sleep disturbances, anxiety, and depression. Sleep, 2013, 36(7), 1059-1068. doi: 10.5665/sleep.2810 PMID: 23814343
- Cardinali, D.P.; Srinivasan, V.; Brzezinski, A.; Brown, G.M. Melatonin and its analogs in insomnia and depression. J. Pineal Res., 2012, 52(4), 365-375. doi: 10.1111/j.1600-079X.2011.00962.x PMID: 21951153
- van Santen, A.; Vreeburg, S.A.; Van der Does, A.J.W.; Spinhoven, P.; Zitman, F.G.; Penninx, B.W.J.H. Psychological traits and the cortisol awakening response: Results from the Netherlands study of depression and anxiety. Psychoneuroendocrinology, 2011, 36(2), 240-248. doi: 10.1016/j.psyneuen.2010.07.014 PMID: 20724080
- Deng, J.; Zhou, F.; Hou, W.; Silver, Z.; Wong, C.Y.; Chang, O.; Huang, E.; Zuo, Q.K. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann. N. Y. Acad. Sci., 2021, 1486(1), 90-111. doi: 10.1111/nyas.14506 PMID: 33009668
- Donzella, S.M.; Kohler, L.N.; Crane, T.E.; Jacobs, E.T.; Ernst, K.C.; Bell, M.L.; Catalfamo, C.J.; Begay, R.; Pogreba-Brown, K.; Farland, L.V. COVID-19 infection, the COVID-19 pandemic, and changes in sleep. Front. Public Health, 2022, 9, 795320. doi: 10.3389/fpubh.2021.795320 PMID: 35174134
- Pellitteri, G.; Surcinelli, A.; De Martino, M.; Fabris, M.; Janes, F.; Bax, F.; Marini, A.; Milanic, R.; Piani, A.; Isola, M.; Gigli, G.L.; Valente, M. Sleep alterations following COVID-19 are associated with both neuroinflammation and psychological disorders, although at different times. Front. Neurol., 2022, 13, 929480. doi: 10.3389/fneur.2022.929480 PMID: 36062000
- Abdelghani, M.; Alsadik, M.; Abdelmoaty, A.; Atwa, S.; Said, A.; Hassan, M. Sleep disturbances following recovery from COVID-19: A comparative cross-sectional study in Egypt. East. Mediterr. Health J., 2022, 28(1), 14-22. doi: 10.26719/emhj.22.006 PMID: 35165874
- El Sayed, S.; Gomaa, S.; Shokry, D.; Kabil, A.; Eissa, A. Sleep in post-COVID-19 recovery period and its impact on different domains of quality of life. Egypt. J. Neurol. Psychiat. Neurosurg., 2021, 57(1), 172. doi: 10.1186/s41983-021-00429-7 PMID: 34924750
- Camargo-Martínez, W.; Lozada-Martínez, I.; Escobar-Collazos, A.; Navarro-Coronado, A.; Moscote-Salazar, L.; Pacheco-Hernández, A.; Janjua, T.; Bosque-Varela, P. Post-COVID-19 neurological syndrome: Implications for sequelaes treatment. J. Clin. Neurosci., 2021, 88, 219-225. doi: 10.1016/j.jocn.2021.04.001 PMID: 33992187
- Zildzic, M.; Salihefendic, D.; Masic, I. Non-pharmacological measures in the prevention and treatment of COVID-19 infection. Med. Arh., 2021, 75(4), 307-312. doi: 10.5455/medarh.2021.75.307-312 PMID: 34759453
- Ekhtiari, H.; Rezapour, T.; Aupperle, R.L.; Paulus, M.P. Neuroscience-informed psychoeducation for addiction medicine: A neurocognitive perspective. Prog. Brain Res., 2017, 235, 239-264. doi: 10.1016/bs.pbr.2017.08.013 PMID: 29054291
- DeRubeis, R.J.; Hollon, S.D.; Amsterdam, J.D.; Shelton, R.C.; Young, P.R.; Salomon, R.M.; OReardon, J.P.; Lovett, M.L.; Gladis, M.M.; Brown, L.L.; Gallop, R. Cognitive therapy vs. medications in the treatment of moderate to severe depression. Arch. Gen. Psychiatry, 2005, 62(4), 409-416. doi: 10.1001/archpsyc.62.4.409 PMID: 15809408
- Thoma, N.; Pilecki, B.; McKay, D. Contemporary cognitive behavior therapy: A review of theory, history, and evidence. Psychodyn. Psychiatry, 2015, 43(3), 423-461. doi: 10.1521/pdps.2015.43.3.423 PMID: 26301761
- Brewin, C.R. Theoretical foundations of cognitive-behavior therapy for anxiety and depression. Annu. Rev. Psychol., 1996, 47(1), 33-57. doi: 10.1146/annurev.psych.47.1.33 PMID: 8624137
- Benjamin, C.L.; Puleo, C.M.; Settipani, C.A.; Brodman, D.M.; Edmunds, J.M.; Cummings, C.M.; Kendall, P.C. History of cognitive-behavioral therapy in youth. Child Adolesc. Psychiatr. Clin. N. Am., 2011, 20(2), 179-189. doi: 10.1016/j.chc.2011.01.011 PMID: 21440849
- McKay, D.; Sookman, D.; Neziroglu, F.; Wilhelm, S.; Stein, D.J.; Kyrios, M.; Matthews, K.; Veale, D. Efficacy of cognitive-behavioral therapy for obsessivecompulsive disorder. Psychiatry Res., 2015, 225(3), 236-246. doi: 10.1016/j.psychres.2014.11.058 PMID: 25613661
- Zhu, Z.; Zhang, L.; Jiang, J.; Li, W.; Cao, X.; Zhou, Z.; Zhang, T.; Li, C. Comparison of psychological placebo and waiting list control conditions in the assessment of cognitive behavioral therapy for the treatment of generalized anxiety disorder: A meta-analysis. Shanghai Jingshen Yixue, 2014, 26(6), 319-331. PMID: 25642106
- Johansson, R.; Andersson, G. Internet-based psychological treatments for depression. Expert Rev. Neurother., 2012, 12(7), 861-870. doi: 10.1586/ern.12.63 PMID: 22853793
- Altena, E.; Micoulaud-Franchi, J.A.; Geoffroy, P.A.; Sanz-Arigita, E.; Bioulac, S.; Philip, P. The bidirectional relation between emotional reactivity and sleep: From disruption to recovery. Behav. Neurosci., 2016, 130(3), 336-350. doi: 10.1037/bne0000128 PMID: 26866361
- Morin, C.M.; Inoue, Y.; Kushida, C.; Poyares, D.; Winkelman, J. Endorsement of European guideline for the diagnosis and treatment of insomnia by the World Sleep Society. Sleep Med., 2021, 81, 124-126. doi: 10.1016/j.sleep.2021.01.023 PMID: 33667998
- Baglioni, C.; Altena, E.; Bjorvatn, B.; Blom, K.; Bothelius, K.; Devoto, A.; Espie, C.A.; Frase, L.; Gavriloff, D.; Tuuliki, H.; Hoflehner, A.; Högl, B.; Holzinger, B.; Järnefelt, H.; Jernelöv, S.; Johann, A.F.; Lombardo, C.; Nissen, C.; Palagini, L.; Peeters, G.; Perlis, M.L.; Posner, D.; Schlarb, A.; Spiegelhalder, K.; Wichniak, A.; Riemann, D. The European academy for cognitive behavioural therapy for insomnia: An initiative of the european insomnia network to promote implementation and dissemination of treatment. J. Sleep Res., 2019, 29. PMID: 31856367
- Morin, C.M.; Vallières, A.; Guay, B.; Ivers, H.; Savard, J.; Mérette, C.; Bastien, C.; Baillargeon, L. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA, 2009, 301(19), 2005-2015. doi: 10.1001/jama.2009.682 PMID: 19454639
- Randall, C.; Nowakowski, S.; Ellis, J.G. Managing acute insomnia in prison: Evaluation of a "one-shot" cognitive behavioral therapy for insomnia (CBT-I) intervention. Behav. Sleep Med., 2019, 17(6), 827-836. doi: 10.1080/15402002.2018.1518227 PMID: 30289290
- Shah, S.M.A.; Mohammad, D.; Qureshi, M.F.H.; Abbas, M.Z.; Aleem, S. Prevalence, psychological responses and associated correlates of depression, anxiety and stress in a global population, during the coronavirus disease (COVID-19) pandemic. Community Ment. Health J., 2020, 1-10. PMID: 33108569
- Bastien, C.H.; Morin, C.M.; Ouellet, M.C.; Blais, F.C.; Bouchard, S. Cognitive-behavioral therapy for insomnia: Comparison of individual therapy, group therapy, and telephone consultations. J. Consult. Clin. Psychol., 2004, 72(4), 653-659. doi: 10.1037/0022-006X.72.4.653 PMID: 15301650
- Fuller, K.H.; Waters, W.F.; Binks, P.G.; Anderson, T. Generalized anxiety and sleep architecture: A polysomnographic investigation. Sleep, 1997, 20(5), 370-376. doi: 10.1093/sleep/20.5.370 PMID: 9381061
- Liu, N.; Zhang, F.; Wei, C.; Jia, Y.; Shang, Z.; Sun, L.; Wu, L.; Sun, Z.; Zhou, Y.; Wang, Y.; Liu, W. Prevalence and predictors of PTSS during COVID-19 outbreak in China hardest-hit areas: Gender differences matter. Psychiatry Res., 2020, 287, 112921-112921. doi: 10.1016/j.psychres.2020.112921 PMID: 32240896
- Kim, H.; Hegde, S.; LaFiura, C.; Raghavan, M.; Luong, E.; Cheng, S.; Rebholz, C.M.; Seidelmann, S.B. COVID-19 illness in relation to sleep and burnout. BMJ Nutrition, Prevention & Health, 2021. doi: 10.1136/bmjnph-2021-000228
- Hofmann, S.G.; Gómez, A.F. Mindfulness-based interventions for anxiety and depression. Psychiatr. Clin. North Am., 2017, 40(4), 739-749. doi: 10.1016/j.psc.2017.08.008 PMID: 29080597
- Creswell, J.D. Mindfulness interventions. Annu. Rev. Psychol., 2017, 68, 491-516. doi: 10.1146/annurev-psych-042716-051139 PMID: 27687118
- Carlson, L.E. Mindfulness-based interventions for physical conditions: A narrative review evaluating levels of evidence. ISRN Psychiatry, 2012, 2012, 1-21. doi: 10.5402/2012/651583 PMID: 23762768
- Sanada, K.; Montero-Marin, J.; Barceló-Soler, A.; Ikuse, D.; Ota, M.; Hirata, A.; Yoshizawa, A.; Hatanaka, R.; Valero, M.S.; Demarzo, M.; Campayo, J.G.; Iwanami, A. Effects of mindfulness-based interventions on biomarkers and low-grade inflammation in patients with psychiatric disorders: A meta-analytic review. Int. J. Mol. Sci., 2020, 21(7), 2484. doi: 10.3390/ijms21072484 PMID: 32260096
- Roque-Lopez, S.; Llanez-Anaya, E.; Álvarez-López, M.J.; Everts, M.; Fernández, D.; Davidson, R.J.; Kaliman, P. Mental health benefits of a 1-week intensive multimodal group program for adolescents with multiple adverse childhood experiences. Child Abuse Negl., 2021, 122, 105349. doi: 10.1016/j.chiabu.2021.105349 PMID: 34628152
- Juul, L.; Pallesen, K.J.; Bjerggaard, M.; Nielsen, C.; Fjorback, L.O. A pilot randomised trial comparing a mindfulness-based stress reduction course, a locally-developed stress reduction intervention and a waiting list control group in a real-life municipal health care setting. BMC Public Health, 2020, 20(1), 409. doi: 10.1186/s12889-020-08470-6 PMID: 32228533
- Pascoe, M.C.; Thompson, D.R.; Jenkins, Z.M.; Ski, C.F. Mindfulness mediates the physiological markers of stress: Systematic review and meta-analysis. J. Psychiatr. Res., 2017, 95, 156-178. doi: 10.1016/j.jpsychires.2017.08.004 PMID: 28863392
- Chadi, N.; Weisbaum, E.; Vo, D.X.; Ahola Kohut, S. Mindfulness-based interventions for adolescents: Time to consider telehealth. J. Altern. Complement. Med., 2020, 26(3), 172-175. doi: 10.1089/acm.2019.0302 PMID: 31765222
- DeVries, A.C.; Glasper, E.R.; Detillion, C. E. Social modulation of stress responses. Physiol Behav, 2003, 79, 399-407. doi: 10.1016/s0031-9384(03)00152-5 PMID: 12954434
- Xiao, H.; Zhang, Y.; Kong, D.; Li, S.; Yang, N. Social capital and sleep quality in individuals who self-isolated for 14 days during the coronavirus disease 2019 (COVID-19) outbreak in january 2020 in China. Med. Sci. Monit., 2020, 26, e923921. doi: 10.12659/MSM.923921 PMID: 32194290
- Basner, M.; Fomberstein, K.M.; Razavi, F.M.; Banks, S.; William, J.H.; Rosa, R.R.; Dinges, D.F. American time use survey: Sleep time and its relationship to waking activities. Sleep, 2007, 30(9), 1085-1095. doi: 10.1093/sleep/30.9.1085 PMID: 17910380
- Kent de Grey, R.G.; Uchino, B.N.; Trettevik, R.; Cronan, S.; Hogan, J.N. Social support and sleep: A meta-analysis. Health Psychol., 2018, 37(8), 787-798. doi: 10.1037/hea0000628 PMID: 29809022
- Peng, Y.; Ao, M.; Dong, B.; Jiang, Y.; Yu, L.; Chen, Z.; Hu, C.; Xu, R. Anti-inflammatory effects of curcumin in the inflammatory diseases: Status, limitations and countermeasures. Drug Des. Devel. Ther., 2021, 15, 4503-4525. doi: 10.2147/DDDT.S327378 PMID: 34754179
- Xu, Y.; Ku, B.; Cui, L.; Li, X.; Barish, P.A.; Foster, T.C.; Ogle, W.O. Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res., 2007, 1162, 9-18. doi: 10.1016/j.brainres.2007.05.071 PMID: 17617388
- Nouri-Vaskeh, M.; Afshan, H.; Malek Mahdavi, A.; Alizadeh, L.; Fan, X.; Zarei, M. Curcumin ameliorates health-related quality of life in patients with liver cirrhosis: A randomized, double-blind placebo-controlled trial. Complement. Ther. Med., 2020, 49, 102351. doi: 10.1016/j.ctim.2020.102351 PMID: 32147077
- Aguiar, S.; Borowski, T. Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation Res., 2013, 16(4), 313-326. doi: 10.1089/rej.2013.1431 PMID: 23772955
- Simpson, T.; Pase, M.; Stough, C. Bacopa monnieri as an antioxidant therapy to reduce oxidative stress in the aging brain. Evid. Based Complement. Alternat. Med., 2015, 2015, 1-9. doi: 10.1155/2015/615384 PMID: 26413126
- Lopresti, A.L.; Smith, S.J.; Ali, S.; Metse, A.P.; Kalns, J.; Drummond, P.D. Effects of a Bacopa monnieri extract (Bacognize®) on stress, fatigue, quality of life and sleep in adults with self-reported poor sleep: A randomised, double-blind, placebo-controlled study. J. Funct. Foods, 2021, 85, 104671. doi: 10.1016/j.jff.2021.104671
- Shetty, S.K.; Rao, P.N.; U, S.; Raj, A.; Ks, S.; Sv, S. The effect of brahmi (Bacopa monnieri (L.) Pennell) on depression, anxiety and stress during COVID-19. Eur. J. Integr. Med., 2021, 48, 101898. doi: 10.1016/j.eujim.2021.101898
- Mancuso, C.; Santangelo, R. Panax ginseng and Panax quinquefolius: From pharmacology to toxicology. Food Chem. Toxicol., 2017, 107(Pt A), 362-372. doi: 10.1016/j.fct.2017.07.019 PMID: 28698154
- Yi, Y.S. Potential benefits of ginseng against COVID-19 by targeting inflammasomes. J. Ginseng Res., 2022, 46(6), 722-730. doi: 10.1016/j.jgr.2022.03.008 PMID: 35399195
- Jeong Han, H.; Yun Kim, H.; Joon Choi, J.; Ahn, S.Y.; Lee, S.H.; Oh, K.W.; Kim, S.Y. Effects of red ginseng extract on sleeping behaviors in human volunteers. J. Ethnopharmacol., 2013, 149(2), 597-599. doi: 10.1016/j.jep.2013.07.005 PMID: 23872254
- Hardeland, R. Melatonin and inflammation-story of a double-edged blade. J. Pineal Res., 2018, 65(4), e12525. doi: 10.1111/jpi.12525 PMID: 30242884
- Reiter, R.J.; Tan, D.X.; Mayo, J.C.; Sainz, R.M.; Leon, J.; Czarnocki, Z. Melatonin as an antioxidant: Biochemical mechanisms and pathophysiological implications in humans. Acta Biochim. Pol., 2003, 50(4), 1129-1146. doi: 10.18388/abp.2003_3637 PMID: 14740000
- Sinha, B.; Wu, Q.; Li, W.; Tu, Y.; Sirianni, A.C.; Chen, Y.; Jiang, J.; Zhang, X.; Chen, W.; Zhou, S.; Reiter, R.J.; Manning, S.M.; Patel, N.J.; Aziz-Sultan, A.M.; Inder, T.E.; Friedlander, R.M.; Fu, J.; Wang, X. Protection of melatonin in experimental models of newborn hypoxic-ischemic brain injury through MT1 receptor. J. Pineal Res., 2018, 64(1), e12443. doi: 10.1111/jpi.12443 PMID: 28796402
- Wurtman, R.J.; Axelrod, J.; Phillips, L.S. Melatonin synthesis in the pineal gland: control by light. Science, 1963, 142(3595), 1071-1073. doi: 10.1126/science.142.3595.1071 PMID: 14068225
- Zisapel, N. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. Br. J. Pharmacol., 2018, 175(16), 3190-3199. doi: 10.1111/bph.14116 PMID: 29318587
- Juricek, L.; Xavier, C. The aryl hydrocarbon receptor and the nervous system. Int. J. Mol. Sci., 2018, 19(9), 25049. doi: 10.3390/ijms19092504
- Lee, K.; Hwang, O.J.; Back, K. Rice N-acetylserotonin deacetylase regulates melatonin levels in transgenic rice. Melatonin Res., 2020, 3(1), 32-42. doi: 10.32794/mr11250046
- Coto-Montes, A.; Boga, J.; Tan, D.; Reiter, R. Melatonin as a potential agent in the treatment of sarcopenia. Int. J. Mol. Sci., 2016, 17(10), 1771. doi: 10.3390/ijms17101771 PMID: 27783055
- Sieck, G.C. Physiology in perspective: Physiological systems respond to time. Physiology , 2020, 35(2), 84-85. doi: 10.1152/physiol.00002.2020 PMID: 32024427
- Huang, S.H.; Cao, X.J.; Liu, W.; Shi, X.Y.; Wei, W. Inhibitory effect of melatonin on lung oxidative stress induced by respiratory syncytial virus infection in mice. J. Pineal Res., 2010, 48(2), 109-116. doi: 10.1111/j.1600-079X.2009.00733.x PMID: 20070490
- Huang, S.H.; Cao, X.J.; Wei, W. Melatonin decreases TLR3-mediated inflammatory factor expression via inhibition of NF-kappa B activation in respiratory syncytial virus-infected RAW264.7 macrophages. J. Pineal. Res.2008; 45(1): 93-100. doi: 10.1111/j.1600-079X.2008.00560.x.
- Miller, S.C.; Pandi, P.S.R.; Esquifino, A.I.; Cardinali, D.P.; Maestroni, G.J.M. The role of melatonin in immuno-enhancement: Potential application in cancer. Int. J. Exp. Pathol., 2006, 87(2), 81-87. doi: 10.1111/j.0959-9673.2006.00474.x PMID: 16623752
- Zhang, R.; Wang, X.; Ni, L.; Di, X.; Ma, B.; Niu, S.; Liu, C.; Reiter, R.J. COVID-19: Melatonin as a potential adjuvant treatment. Life Sci., 2020, 250, 117583-117583. doi: 10.1016/j.lfs.2020.117583 PMID: 32217117
- Wang, Q.L.; Yang, L.; Peng, Y.; Gao, M.; Yang, M.S.; Xing, W.; Xiao, X.Z. Ginsenoside Rg1 regulates SIRT1 to ameliorate sepsis-induced lung inflammation and injury viainhibiting endoplasmic reticulum stress and inflammation. Mediators Inflamm., 2019, 2019, 1-10. doi: 10.1155/2019/6453296 PMID: 30918470
- Sun, C.K.; Lee, F.Y.; Kao, Y.H.; Chiang, H.J.; Sung, P.H.; Tsai, T.H.; Lin, Y.C.; Leu, S.; Wu, Y.C.; Lu, H.I.; Chen, Y.L.; Chung, S.Y.; Su, H.L.; Yip, H.K. Systemic combined melatonin-mitochondria treatment improves acute respiratory distress syndrome in the rat. J. Pineal Res., 2015, 58(2), 137-150. doi: 10.1111/jpi.12199 PMID: 25491480
- Shang, Y.; Xu, S.P.; Wu, Y.; Jiang, Y.X.; Wu, Z.Y.; Yuan, S.Y.; Yao, S.L. Melatonin reduces acute lung injury in endotoxemic rats. Chin. Med. J., 2009, 122(12), 1388-1393. PMID: 19567158
- Pedrosa, A.M.C.; Weinlich, R.; Mognol, G.P.; Robbs, B.K.; Viola, J.P.B.; Campa, A.; Amarante-Mendes, G.P. Melatonin protects CD4+ T cells from activation-induced cell death by blocking NFAT-mediated CD95 ligand upregulation. J. Immunol., 2010, 184(7), 3487-3494. doi: 10.4049/jimmunol.0902961 PMID: 20181888
- Habtemariam, S.; Daglia, M.; Sureda, A.; Selamoglu, Z.; Fuat, G.M.; Mohammad, NS. Melatonin and respiratory diseases: A review. Curr. Top. Med. Chem., 2016, 17(4), 467-488. doi: 10.2174/1568026616666160824120338 PMID: 27558675
- Mańka, S.; Majewska, E. Immunoregulatory action of melatonin. The mechanism of action and the effect on inflammatory cells. Postepy Hig. Med. Dosw., 2016, 70(0), 1059-1067. doi: 10.5604/17322693.1221001 PMID: 27708210
- Korkmaz, A.; Reiter, R.J.; Topal, T.; Manchester, L.C.; Oter, S.; Tan, D.X. Melatonin: an established antioxidant worthy of use in clinical trials. Mol. Med., 2009, 15(1-2), 43-50. doi: 10.2119/molmed.2008.00117 PMID: 19011689
- Shirey, K.A.; Lai, W.; Scott, A.J.; Lipsky, M.; Mistry, P.; Pletneva, L.M.; Karp, C.L.; McAlees, J.; Gioannini, T.L.; Weiss, J.; Chen, W.H.; Ernst, R.K.; Rossignol, D.P.; Gusovsky, F.; Blanco, J.C.G.; Vogel, S.N. The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature, 2013, 497(7450), 498-502. doi: 10.1038/nature12118 PMID: 23636320
- Sui, X. Inhibition of the NF-κB signaling pathway on endothelial cell function and angiogenesis in mice with acute cerebral infarction. J. Biol. Regul. Homeost. Agents, 2019, 33(2), 375-384. PMID: 30945527
- Zhao, Y.; Wang, H.; Chen, W.; Chen, L.; Liu, D.; Wang, X.; Wang, X. Melatonin attenuates white matter damage after focal brain ischemia in rats by regulating the TLR4/NF-κB pathway. Brain Res. Bull., 2019, 150, 168-178. doi: 10.1016/j.brainresbull.2019.05.019 PMID: 31158461
- Cuzzocrea, S.; Russel, J.R. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. Eur J Pharmacol, 2001, 426(1-2), 1-10. doi: 10.1016/s0014-2999(01)01175-x PMID: 11525764
- Gitto, E.; Karbownik, M.; Reiter, R.J.; Tan, D.X.; Cuzzocrea, S.; Chiurazzi, P.; Cordaro, S.; Corona, G.; Trimarchi, G.; Barberi, I. Effects of melatonin treatment in septic newborns. Pediatr. Res., 2001, 50(6), 756-760. doi: 10.1203/00006450-200112000-00021 PMID: 11726736
- Mundigler, G.; Delle-Karth, G.; Koreny, M.; Zehetgruber, M.; Steindl-Munda, P.; Marktl, W.; Fertl, L.; Siostrzonek, P. Impaired circadian rhythm of melatonin secretion in sedated critically ill patients with severe sepsis. Crit. Care Med., 2002, 30(3), 536-540. doi: 10.1097/00003246-200203000-00007 PMID: 11990911
- Tamura, D.Y.; Moore, E.E.; Partrick, D.A.; Johnson, J.L.; Offner, P.J.; Silliman, C.C. Acute hypoxemia in humans enhances the neutrophil inflammatory response. Shock, 2002, 17(4), 269-273. doi: 10.1097/00024382-200204000-00005 PMID: 11954825
- Gitto, E.; Reiter, R.J.; Sabatino, G.; Buonocore, G.; Romeo, C.; Gitto, P.; Buggé, C.; Trimarchi, G.; Barberi, I. Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment. J. Pineal Res., 2005, 39(3), 287-293. doi: 10.1111/j.1600-079X.2005.00251.x PMID: 16150110
- Bazyar, H.; Gholinezhad, H.; Moradi, L.; Salehi, P.; Abadi, F.; Ravanbakhsh, M.; Zare Javid, A. The effects of melatonin supplementation in adjunct with non-surgical periodontal therapy on periodontal status, serum melatonin and inflammatory markers in type 2 diabetes mellitus patients with chronic periodontitis: a double-blind, placebo-controlled trial. Inflammopharmacology, 2019, 27(1), 67-76. doi: 10.1007/s10787-018-0539-0 PMID: 30328031
- Sánchez-López, A.L.; Ortiz, G.G.; Pacheco-Moises, F.P.; Mireles-Ramírez, M.A.; Bitzer-Quintero, O.K.; Delgado-Lara, D.L.C.; Ramírez-Jirano, L.J.; Velázquez-Brizuela, I.E. Efficacy of melatonin on serum pro-inflammatory cytokines and oxidative stress markers in relapsing remitting multiple sclerosis. Arch. Med. Res., 2018, 49(6), 391-398. doi: 10.1016/j.arcmed.2018.12.004 PMID: 30595364
- Kücükakin, B.; Lykkesfeldt, J.; Nielsen, H.J.; Reiter, R.J.; Rosenberg, J.; Gögenur, I. Utility of melatonin to treat surgical stress after major vascular surgery a safety study. J. Pineal Res., 2008, 44(4), 426-431. doi: 10.1111/j.1600-079X.2007.00545.x PMID: 18205732
- Zhao, Z.; Lu, C.; Li, T.; Wang, W.; Ye, W.; Zeng, R.; Ni, L.; Lai, Z.; Wang, X.; Liu, C. The protective effect of melatonin on brain ischemia and reperfusion in rats and humans: In vivo assessment and a randomized controlled trial. J. Pineal Res., 2018, 65(4), e12521. doi: 10.1111/jpi.12521 PMID: 30098076
- Zarezadeh, M.; Khorshidi, M.; Emami, M.; Janmohammadi, P.; Kord-varkaneh, H.; Mousavi, S.M.; Mohammed, S.H.; Saedisomeolia, A.; Alizadeh, S. Melatonin supplementation and pro-inflammatory mediators: A systematic review and meta-analysis of clinical trials. Eur. J. Nutr., 2020, 59(5), 1803-1813. doi: 10.1007/s00394-019-02123-0 PMID: 31679041
- Anderson, G.; Reiter, R.J. Melatonin: Roles in influenza, COVID-19, and other viral infections. Rev. Med. Virol., 2020, 30(3), e2109. doi: 10.1002/rmv.2109 PMID: 32314850
- Begum, R.; Mamun-Or-Rashid, A.N.M.; Lucy, T.T.; Pramanik, M.K.; Sil, B.K.; Mukerjee, N.; Tagde, P.; Yagi, M.; Yonei, Y. Potential therapeutic approach of melatonin against omicron and some other variants of SARS-CoV-2. Molecules, 2022, 27(20), 6934. doi: 10.3390/molecules27206934 PMID: 36296527
- Alizadeh, N.; Dianatkhah, M.; Alimohamadi, Y.; Moradi, H.; Akbarpour, S.; Akrami, M.; Mansouri, F.; Faraji, N.; Rezaie, Z.; Alizadeh, M.; Hosamirudsari, H. High dose melatonin as an adjuvant therapy in intubated patients with COVID-19: A randomized clinical trial. J. Taibah Univ. Med. Sci., 2022, 17(3), 454-460. doi: 10.1016/j.jtumed.2022.04.012 PMID: 35581997
- Minich, D.M.; Henning, M.; Darley, C.; Fahoum, M.; Schuler, C.B.; Frame, J. Is melatonin the "next vitamin D"?: A review of emerging science, clinical uses, safety, and dietary supplements. Nutrients, 2022, 14(19), 3934. doi: 10.3390/nu14193934 PMID: 36235587
- Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Moher, D. Updating guidance for reporting systematic reviews: Development of the PRISMA 2020 statement. J. Clin. Epidemiol., 2021, 134, 103-112. doi: 10.1016/j.jclinepi.2021.02.003 PMID: 33577987
- Hasan, Z.T.; Atrakji, D.M.Q.Y.M.A.A.; Mehuaiden, D.A.K. The effect of melatonin on thrombosis, sepsis and mortality rate in COVID-19 patients. Int. J. Infect. Dis., 2022, 114, 79-84. doi: 10.1016/j.ijid.2021.10.012 PMID: 34653660
- Mousavi, S.A.; Heydari, K.; Mehravaran, H.; Saeedi, M.; Alizadeh-Navaei, R.; Hedayatizadeh-Omran, A.; Shamshirian, A. Melatonin effects on sleep quality and outcomes of COVID-19 patients: An open-label, randomized, controlled trial. J. Med. Virol., 2022, 94(1), 263-271. doi: 10.1002/jmv.27312 PMID: 34460132
- Farnoosh, G.; Akbariqomi, M.; Badri, T.; Bagheri, M.; Izadi, M.; Saeedi-Boroujeni, A.; Rezaie, E.; Ghaleh, H.E.G.; Aghamollaei, H.; Fasihi-ramandi, M.; Hassanpour, K.; Alishiri, G. Efficacy of a low dose of melatonin as an adjunctive therapy in hospitalized patients with COVID-19: A randomized, double-blind clinical trial. Arch. Med. Res., 2022, 53(1), 79-85. doi: 10.1016/j.arcmed.2021.06.006 PMID: 34229896
- Alizadeh, Z.; Keyhanian, N.; Ghaderkhani, S.; Dashti-Khavidaki, S.; Shokouhi, S.R.; Pourpak, Z. A pilot study on controlling coronavirus disease 2019 (COVID-19) inflammation using melatonin supplement. Iran. J. Allergy Asthma Immunol., 2021, 20(4), 494-499. doi: 10.18502/ijaai.v20i4.6959 PMID: 34418903
- Lan, S.H.; Lee, H.Z.; Chao, C.M.; Chang, S.P.; Lu, L.C.; Lai, C.C. Efficacy of melatonin in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. J. Med. Virol., 2022, 94(5), 2102-2107. doi: 10.1002/jmv.27595 PMID: 35032042
- Mazza, M.G.; Palladini, M.; Poletti, S.; Benedetti, F. Post-COVID-19 depressive symptoms: Epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs, 2022, 36(7), 681-702. doi: 10.1007/s40263-022-00931-3 PMID: 35727534
补充文件
